Lots of nice deals to report this week from New England’s tech and life sciences sectors.
—E-mail archiving provider Sonian indicated to the SEC that it had raised $4 million in an equity offering that could total $9 million. Previous backers of the Needham, MA-based firm include Prism VentureWorks and Summerhill Venture Partners.
—BG Medicine of Waltham, MA, set the targeted price range for its proposed IPO at $13 to $15 per share. With 4.75 million shares in the offering, that means the diagnostics firm could raise up to $71.25 million.
—Cambridge, MA-based Semprus BioSciences, an MIT spinoff out to commercialize new coatings for medical devices, raised $18 million in Series B equity financing. SR One and Foundation Medical Partners, both new investors, led the deal, which was joined by existing backers 5AM Ventures and Pangaea Ventures.
—Thermo Fisher Scientific (NYSE: [[ticker:TMO]]), the Waltham-based provider of research tools and services, agreed to shell out $2.1 billion in cash for the outstanding shares Sunnyvale, CA-based Dionex (NASDAQ: [[ticker:DNEX]]).
—French drug maker Sanofi-Aventis extended its tender offer for the shares of Cambridge, MA-based Genzyme (NASDAQ:[[ticker:GENZ]]) until January 21. Genzyme has repeatedly said that the unsolicited $69 per share offer, worth $18.5 billion in total, undervalues the company and its pipeline of drugs.
—Woburn, MA-based video game developer 8D World closed a Series B financing round worth $5.25 million. Japan’s Mizuho Capital and return backers Spark Capital and Gobi Partners participated in the deal.
—Nano-Terra of Cambridge raised $17.2 million in an offering of equity and rights. The round appears to be the biggest one yet for the 5-year-old nanotech development firm, which is out to commercialize technology from the lab of Harvard chemist George Whitesides.
—Rive Technology, also of Cambridge, raised $25 million in a Series C financing round led by new investor Blackstone Group and joined by Charles River Ventures, Advanced Technology Ventures, and Nth Power. The cash will help Rive do commercial tests of its MIT-developed catalyst technology, which is designed to let oil refiners get more useable fuel out of crude oil.
—Boston’s SensorLogic, a provider of cloud-based platforms for deploying applications across multiple devices, raised $5 million from existing investors. Sevin Rosen Funds and Boston Millennia Partners led the deal and UPS Strategic Enterprise Fund and Covera Ventures joined in.
